Early drug forming screening
The early drug formation of compounds can be studied through toxicity prediction, pharmacokinetic screening, and efficacy screening studies, including cardiac toxicity risk prediction, tolerance dose of related species, bioavailability, cytotoxicity, and genotoxicity.
■ Non GLP cardiovascular safety screening test: hERG patch clamp
■ Tolerance exploration: rats, mice, dogs, monkeys
■ Cytotoxicity screening study
■ Genotoxicity screening study
■ Non GLP cardiovascular safety screening test: hERG patch clamp
■ Tolerance exploration: rats, mice, dogs, monkeys
■ Cytotoxicity screening study
■ Genotoxicity screening study
